PharmaCyte Biotech Inc. (PMCB): Price and Financial Metrics
PMCB Price/Volume Stats
Current price | $1.11 | 52-week high | $2.42 |
Prev. close | $1.10 | 52-week low | $1.00 |
Day low | $1.07 | Volume | 10,810 |
Day high | $1.11 | Avg. volume | 15,085 |
50-day MA | $1.07 | Dividend yield | N/A |
200-day MA | $1.48 | Market Cap | 7.59M |
PMCB Stock Price Chart Interactive Chart >
PharmaCyte Biotech Inc. (PMCB) Company Bio
PharmaCyte Biotech, Inc. (PharmaCyte) is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.
PMCB Price Returns
1-mo | 9.90% |
3-mo | -3.48% |
6-mo | -31.27% |
1-year | -46.12% |
3-year | -53.56% |
5-year | -96.37% |
YTD | -29.30% |
2024 | -27.31% |
2023 | -26.28% |
2022 | 17.20% |
2021 | -75.12% |
2020 | -83.46% |
Loading social stream, please wait...